Metraipolis › archive › dc_e563c01e82eb

IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities — Europe PMC PMID:41660621

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41660621
DOI
10.3389/fimmu.2025.1736606
License (as archived)
solo-consultazione
Archived
2026-11-06T18:54:22.740Z
SHA-256 of the archived text
a132efb9604df0aed16058448e9ed4d0934f69e7db453ebcb506d0602da7d1cb
Stable URL of this page
https://metraipolis.com/documento/dc_e563c01e82eb

How to cite

IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities — Europe PMC PMID:41660621 — Europe PMC (en), https://europepmc.org/article/MED/41660621 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e563c01e82eb (Metraipolis archive dc_e563c01e82eb, sha256 a132efb9604df0aed16058448e9ed4d0934f69e7db453ebcb506d0602da7d1cb)
BibTeX
@misc{dce563c01e82eb,
  title = {IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities — Europe PMC PMID:41660621},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41660621},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e563c01e82eb; sha256 a132efb9604df0aed16058448e9ed4d0934f69e7db453ebcb506d0602da7d1cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41660621. Agents can read the archived copy with the MCP tool read_document.